Artificial Intelligence

Sino Biological Launches New Target Protein Collections for AI-Driven Discovery

· GlobeWire Daily Editorial Desk · Source: www.prnewswire.com

2 min read

Key takeawaysSino Biological, Inc. has announced the introduction of two specialized protein collections designed to support researchers in evaluating molecules generated by artificial intelligence. These collections, titled AI-Trusted Proteins and AI-Qualified Proteins, are intended to provide high-quality, experimentally characterized data for therapeutic and…
Sino Biological Introduces AI-Trusted and Qualified Target Protein Collections for AI-Driven Discovery

Image: Sino Biological · Photo source · Resized and letterboxed to 16:9; no AI generation

Overview

Sino Biological, Inc. has announced the introduction of two specialized protein collections designed to support researchers in evaluating molecules generated by artificial intelligence. These collections, titled AI-Trusted Proteins and AI-Qualified Proteins, are intended to provide high-quality, experimentally characterized data for therapeutic and diagnostic development.

AI-Focused Protein Collections

  • AI-Trusted Proteins: This category includes over 600 targets and 960 individual proteins that have been previously utilized in AI-focused validation projects and featured in published research. Characterization data for these proteins may include SPR, BLI, ELISA, and SEC-MALS analysis.
  • AI-Qualified Proteins: This collection encompasses 680+ targets and 1,700+ individual proteins. It is designed to offer researchers experimentally characterized binding activity, including biotinylated formats, to verify AI-designed molecules.

Supporting Research Infrastructure

Sino Biological leverages its '4S System' (Scale, Scope, Speed, and Supply) to manage a catalog of over 11,000 recombinant proteins. Additionally, the company has introduced the 4RISE™ AI Lab Validation Solution. This system is designed to provide integrated wet-lab support, moving research from computational predictions to empirical evidence through:

  • High-throughput protein expression.
  • Binding and affinity characterization.
  • Developability assessments.
  • Functional validation.

Verification and Access

According to Dr. Rob Burgess, Chief Business Officer at Sino Biological US, these resources aim to provide the empirical evidence required to validate computational discoveries. Researchers interested in these collections can explore the company's therapeutic target directory, which covers over 100 diseases across 12 therapeutic areas. Detailed product specifications and data access can be verified through the official Sino Biological website.

Share this article
Read the original source: Sino Biological Introduces AI-Trusted and Qualified Target Protein Collections for AI-Driven Discovery

AI-assisted reporting; source claims are attributed and have not been independently verified.

About the author

GlobeWire Daily Editorial Desk — AI-assisted news based on attributed published sources.

More to read